Answers are grounded in this paper and cite their sources.
Experimental study demonstrates that oral diphosphonates prevent aortic calcification in vitamin D3-treated rats, indicating therapeutic potential against pathological mineral deposition.
Two diphosphonates containing the P-C-P bond, CH(3)C(OH)(PO(3)HNa)(2) and H(2)C(PO(3)HNa)(2), inhibit the crystallization of calcium phosphate in vitro and prevent aortic calcification of rats given large amounts of vitamin D(3). The diphosphonates therefore have effects similar to those described for compounds containing the P-O-P bond but are active when administered orally.
No takes yet. Share an insight, caveat, or question.
Francis et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: